Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06RHC
|
|||
| Former ID |
DNCL003437
|
|||
| Drug Name |
DS-1040
|
|||
| Indication | Ischemic stroke [ICD-11: 8B11.5Z; ICD-9: 434.91] | Phase 1 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H12ClNO3
|
|||
| Canonical SMILES |
COCCNC1=C(C(=O)C2=CC=CC=C2C1=O)Cl
|
|||
| InChI |
1S/C13H12ClNO3/c1-18-7-6-15-11-10(14)12(16)8-4-2-3-5-9(8)13(11)17/h2-5,15H,6-7H2,1H3
|
|||
| InChIKey |
IAPJSKHYZZLKBU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 22272-22-6
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carboxypeptidase B2 (CPB2) | Target Info | Modulator | [2] |
| KEGG Pathway | Complement and coagulation cascades | |||
| Pancreatic secretion | ||||
| Protein digestion and absorption | ||||
| Panther Pathway | Plasminogen activating cascade | |||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
| WikiPathways | Complement and Coagulation Cascades | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02071004) DS1040b/Aspirin Drug/Drug Interaction Study. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Daiichi Sankyo. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.